Article
Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC
2024-11-18
Abstract excerpt
SARS-CoV-2 continues to evolve and spread around the world, and it remains critical to understand the functional consequences of mutations that lead to dominant viral variants. KP.3.1.1 is currently the most prevalent subvariant worldwide, while the recombinant subvariant XEC is exhibiting the fastest growth rate. Here we measured the in vitro neutralization of KP.3.1.1 and XEC by human sera, monoclonal antibodies...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 08d625e8-0b4c-5bd0-84ab-53ecdd774b8e
- DOI
- 10.1101/2024.11.17.624037
